Biocure Technology Balance Sheet Health
Financial Health criteria checks 3/6
Biocure Technology has a total shareholder equity of CA$2.6M and total debt of CA$85.4K, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are CA$3.5M and CA$909.8K respectively.
Key information
3.3%
Debt to equity ratio
CA$85.45k
Debt
Interest coverage ratio | n/a |
Cash | CA$5.46k |
Equity | CA$2.59m |
Total liabilities | CA$909.85k |
Total assets | CA$3.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CURE's short term assets (CA$726.9K) do not cover its short term liabilities (CA$909.8K).
Long Term Liabilities: CURE has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CURE's net debt to equity ratio (3.1%) is considered satisfactory.
Reducing Debt: CURE's debt to equity ratio has reduced from 39.2% to 3.3% over the past 5 years.
Debt Coverage: CURE's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if CURE's interest payments on its debt are well covered by EBIT.